Advertisement

Journal of Genetic Counseling

, Volume 23, Issue 4, pp 566–577 | Cite as

Genetic Testing of Children for Predisposition to Mood Disorders: Anticipating the Clinical Issues

  • Jessica A. Erickson
  • Lili Kuzmich
  • Kelly E. Ormond
  • Erynn Gordon
  • Michael F. Christman
  • Mildred K. Cho
  • Douglas F. LevinsonEmail author
Next Generation Genetic Counseling

Abstract

Large-scale sequencing information may provide a basis for genetic tests for predisposition to common disorders. In this study, participants in the Coriell Personalized Medicine Collaborative (N = 53) with a personal and/or family history of Major Depressive Disorder or Bipolar Disorder were interviewed based on the Health Belief Model around hypothetical intention to test one’s children for probability of developing a mood disorder. Most participants (87 %) were interested in a hypothetical test for children that had high (“90 %”) positive predictive value, while 51 % of participants remained interested in a modestly predictive test (“20 %”). Interest was driven by beliefs about effects of test results on parenting behaviors and on discrimination. Most participants favored testing before adolescence (64 %), and were reluctant to share results with asymptomatic children before adulthood. Participants anticipated both positive and negative effects of testing on parental treatment and on children’s self-esteem. Further investigation will determine whether these findings will generalize to other complex disorders for which early intervention is possible but not clearly demonstrated to improve outcomes. More information is also needed about the effects of childhood genetic testing and sharing of results on parent–child relationships, and about the role of the child in the decision-making process.

Keywords

Genetic testing Children Benefits Risks Positive predictive value Mood disorders Health Belief Model Mood disorders 

Notes

Acknowledgments

This work was supported by NIH grant P50 HG003389. The authors would like to thank Lisa Wawak for her contributions to the recruitment and participant follow-up. We thank Dr. Bettina Meiser for sharing her questionnaires, which served as a starting point for parts of our interview schedule.

Conflict of Interest

Authors Jessica A. Erickson, Lili Kuzmich, Kelly E. Ormond, Erynn Gordon, Michael F. Christman, Mildred K. Cho and Douglas F. Levinson declare that they have no conflict of interest.

Informed Consent

All study procedures were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all participants for inclusion in the study.

Supplementary material

10897_2014_9710_MOESM1_ESM.doc (88 kb)
ESM 1 (DOC 87 kb)

References

  1. Ajzen, I., Brown, T. C., & Carvajal, F. (2004). Explaining the discrepancy between intentions and actions: the case of hypothetical bias in contingent valuation. Personality and Social Psychology Bulletin, 30(9), 1108–1121.CrossRefGoogle Scholar
  2. American Society of Human Genetics. (1995). Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. American Society of Human Genetics Board of Directors, American College of Medical Genetics Board of Directors. American Journal of Human Genetics, 57, 1233–1241.Google Scholar
  3. Arnarson, E. O., & Craighead, W. E. (2011). Prevention of depression among Icelandic adolescents: a 12-month follow-up. Behaviour Research and Therapy, 49(3), 170–4.CrossRefGoogle Scholar
  4. Austin, J. C. (2010). Re-conceptualizing risk in genetic counseling: implication for clinical practice. Journal of Genetic Counseling, 19, 228–234.CrossRefGoogle Scholar
  5. Austin, J. C., Hippman, C., & Honer, W. G. (2012). Descriptive and numeric estimation of risk for psychotic disorders among affected individuals and relatives: implications for clinical practice. Psychiatry Research, 196(1), 52–6.CrossRefGoogle Scholar
  6. Biesecker, B. B., & Peay, H. L. (2013). Genomic sequencing for psychiatric disorders: promise and challenge. International Journal of Neuropsychopharmacology, 16(7), 1667–72.CrossRefGoogle Scholar
  7. Borry, P., Stultiens, L., Nys, H., Cassiman, J. J., & Dierickx, K. (2006). Presymptomatic and predictive genetic testing in minors: a systematic review of guidelines and position papers. Clinical Genetics, 70, 374–381.CrossRefGoogle Scholar
  8. Braff, D. L., & Freedman, R. (2008). Clinically responsible genetic testing in neuropsychiatric patients: a bridge too far and too soon. The American Journal of Psychiatry, 165, 952–955.CrossRefGoogle Scholar
  9. Coors, M. E., Moseley, R., & McGorray, S. (2011). Informed consent process in Alpha-1 testing of at-risk children: views of parents and adults tested as children. COPD, 8, 30–38.CrossRefGoogle Scholar
  10. Corcoran, C., Malaspina, D., & Hercher, L. (2005). Prodromal interventions for schizophrenia vulnerability: the risks of being “at risk”. Schizophrenia Research, 73, 173–184.CrossRefGoogle Scholar
  11. Do, C. B., Hinds, D. A., Francke, U., & Eriksson, N. (2012). Comparison of family history and SNPs for predicting risk of complex disease. PLoS Genetics, 8(10), e1002973.CrossRefGoogle Scholar
  12. Erickson, J. A., & Cho, M. K. (2011). Ethnical considerations and risks in psychiatric genetics: preliminary findings of a study on psychiatric genetic researchers. AJOB Primary Reseach, 2, 52–60.CrossRefGoogle Scholar
  13. Fenwick, A. (2010). Are guidelines for genetic testing of children necessary? Familial Cancer, 9, 23–25.CrossRefGoogle Scholar
  14. Garber, J., et al. (2009). Prevention of depression in at-risk adolescents: a randomized controlled trial. JAMA: The Journal of the American Medical Association, 301, 2215–2224.CrossRefGoogle Scholar
  15. Hoge, S. K., & Appelbaum, P. S. (2012). Ethics and neuropsychiatric genetics: a review of major issues. International Journal of Neuropsychopharmacology, 15, 1547–1557.CrossRefGoogle Scholar
  16. Hoop, J. G., Lapid, M. I., Paulson, R. M., & Roberts, L. W. (2010). Clinical and ethical considerations in pharmacogenetic testing: views of physicians in 3 “early adopting” departments of psychiatry. Journal of Clinical Psychiatry, 71, 745–753.CrossRefGoogle Scholar
  17. Janz, N. K., Champion, V. L., & Strecher, V. J. (2002). The health belief model. In K. Glanz, B. K. Rimer, & F. M. Lewis (Eds.), Health behavior and health education: Theory, research, and practice (3rd ed., pp. 45–66). San Francisco: Jossey-Bass.Google Scholar
  18. Jones, I., Scourfield, J., McCandless, F., & Craddock, N. (2002). Attitudes towards future testing for bipolar disorder susceptibility genes: a preliminary investigation. Journal of Affective Disorders, 71, 189–193.CrossRefGoogle Scholar
  19. Laegsgaard, M. M., Kristensen, A. S., & Mors, O. (2009). Potential consumers’ attitudes toward psychiatric genetic research and testing and factors influencing their intentions to test. Genetic Testing and Molecular Biomarkers, 13, 57–65.CrossRefGoogle Scholar
  20. LaRusse, S., et al. (2005). Genetic susceptibility testing versus family history-based risk assessment: impact on perceived risk of Alzheimer disease. Genetics in Medicine, 7, 48–53.CrossRefGoogle Scholar
  21. Lea, D. H., Kaphingst, K. A., Bowen, D., Lipkus, I., & Hadley, D. W. (2011). Communicating genetic and genomic information: health literacy and numeracy considerations. Public Health Genomics, 14, 279–289.CrossRefGoogle Scholar
  22. Lerman, C., Daly, M., Masny, A., & Balshem, A. (1994). Attitudes about genetic testing for breast-ovarian cancer susceptibility. Journal of Clinical Oncology, 12(4), 843–850.CrossRefGoogle Scholar
  23. Lerman, C., Croyle, R. T., Tercyak, K. P., & Hamann, H. (2002). Genetic testing: psychological aspects and implications. Journal of Consulting and Clinical Psychology, 70, 784–797.CrossRefGoogle Scholar
  24. Malpas, P. J. (2008). Predictive genetic testing of children for adult-onset diseases and psychological harm. Journal of Medical Ethics, 34, 275–278.CrossRefGoogle Scholar
  25. Mand, C., Gillam, L., Delatycki, M. B., Duncan, R. E. (2012). Predictive genetic testing in minors for late-onset conditions: a chronological and analytical review of the ethical arguments. Journal of Medical Ethics, 38, 519–24.CrossRefGoogle Scholar
  26. Marteau, T. M. (1999). Communicating genetic risk information. British Medical Bulletin, 55, 414–428.CrossRefGoogle Scholar
  27. Meiser, B., Mitchell, P. B., McGirr, H., Van Herten, M., & Schofield, P. R. (2005). Implications of genetic risk information in families with a high density of bipolar disorder: an exploratory study. Social Science & Medicine, 60, 109–118.CrossRefGoogle Scholar
  28. Meiser, B., Kasparian, N. A., Mitchell, P. B., Strong, K., Simpson, J. M., Tabassum, L., et al. (2008). Attitudes to genetic testing in families with multiple cases of bipolar disorder. Genetic Testing, 12, 233–243.CrossRefGoogle Scholar
  29. Merikangas, K. R., et al. (2002). Future of genetics of mood disorders research. Biological Psychiatry, 52, 457–477.CrossRefGoogle Scholar
  30. Metcalfe, A., Plumridge, G., Coad, J., Shanks, A., & Gill, P. (2011). Parents’ and children’s communication about genetic risk: a qualitative study, learning from families’ experiences. European Journal of Human Genetics, 19, 640–646.CrossRefGoogle Scholar
  31. Miklowitz, D. J., & Chang, K. D. (2008). Prevention of bipolar disorder in at-risk children: theoretical assumptions and empirical foundations. Development and Psychopathology, 20, 881–897.CrossRefGoogle Scholar
  32. National Society of Genetic Counselors. (2012). Genetic Testing of Minors for Adult-Onset Conditions (position statement). https://doi.org/nsgc.org/p/bl/et/blogid=47&blogaid=28
  33. Parker, M. (2010). Genetic testing in children and young people. Familial Cancer, 9, 15–18.CrossRefGoogle Scholar
  34. Paynter, N. P., Chasman, D. I., Buring, J. E., Shiffman, D., Cook, N. R., & Ridker, P. M. (2009). Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3. Annals of Internal Medicine, 150, 65–72.CrossRefGoogle Scholar
  35. Ross, L. F., Saal, H. M., David, K. L., & Anderson, R. R. (2013). Technical report: ethical and policy issues in genetic testing and screening of children. Genetics in Medicine, 15, 234–245.CrossRefGoogle Scholar
  36. Smith, L. B., Sapers, B., Reus, V. I., & Freimer, N. B. (1996). Attitudes towards bipolar disorder and predictive genetic testing among patients and providers. Journal of Medical Genetics, 33, 544–549.CrossRefGoogle Scholar
  37. Stice, E., Rohde, P., Gau, J. M., & Wade, E. (2010). Efficacy trial of a brief cognitive-behavioral depression prevention program for high-risk adolescents: effects at 1- and 2-year follow-up. Journal of Consulting and Clinical Psychology, 78(6), 856–67.CrossRefGoogle Scholar
  38. Tercyak, K. P., Hensley Alford, S., Emmons, K. M., Lipkus, I. M., Wilfond, B. S., & McBride, C. M. (2011). Parents’ attitudes toward pediatric genetic testing for common disease risk. Pediatrics, 127, e1288–1295.CrossRefGoogle Scholar
  39. Trippitelli, C. L., Jamison, K. R., Folstein, M. F., Bartko, J. J., & DePaulo, J. R. (1998). Pilot study on patients’ and spouses’ attitudes toward potential genetic testing for bipolar disorder. The American Journal of Psychiatry, 155, 899–904.CrossRefGoogle Scholar
  40. Wade, C. H., Wilfond, B. S., & McBride, C. M. (2010). Effects of genetic risk information on children’s psychosocial wellbeing: a systematic review of the literature. Genetics in Medicine, 12, 317–26.CrossRefGoogle Scholar
  41. Wilde, A., Meiser, B., Mitchell, P. B., Hadzi-Pavlovic, D., & Schofield, P. R. (2011). Community interest in predictive genetic testing for susceptibility to major depressive disorder in a large national sample. Psychological Medicine, 41(8), 1605–13.CrossRefGoogle Scholar
  42. Wright, C. F., & Kroese, M. (2010). Evaluation of genetic tests for susceptibility to common complex diseases: why, when and how? Human Genetics, 127, 125–134.CrossRefGoogle Scholar

Copyright information

© The Author(s) 2014

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://doi.org/creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Authors and Affiliations

  • Jessica A. Erickson
    • 1
  • Lili Kuzmich
    • 2
  • Kelly E. Ormond
    • 1
    • 3
  • Erynn Gordon
    • 4
  • Michael F. Christman
    • 4
  • Mildred K. Cho
    • 1
    • 5
  • Douglas F. Levinson
    • 1
    • 6
    Email author
  1. 1.Center for the Integration of Research on Genetics and Ethics of the Stanford Center for Biomedical EthicsStanford UniversityStanfordUSA
  2. 2.Center for Reproductive HealthUniversity of California San Francisco Medical CenterSan FranciscoUSA
  3. 3.Department of GeneticsStanford UniversityStanfordUSA
  4. 4.Coriell Personalized Medicine CollaborativeCoriell Institute for Medical ResearchCamdenUSA
  5. 5.Department of PediatricsStanford UniversityStanfordUSA
  6. 6.Department of Psychiatry and Behavioral SciencesStanford UniversityStanfordUSA

Personalised recommendations